InvestorsHub Logo
Followers 30
Posts 4330
Boards Moderated 0
Alias Born 03/20/2011

Re: dcaf7 post# 20

Tuesday, 06/06/2023 10:15:38 PM

Tuesday, June 06, 2023 10:15:38 PM

Post# of 110
Thank you for the finer details - all understood.

Hopefully we get some further insight at Jeffries on the timeline for Phase 1 data - NSCLC and GBM and further information on attendance at future conferences in 2023.

I'm honestly only expecting data on cohort 1 and 2 in the 2nd half of 2023, if we get some early data on cohort 3 would be a major bonus, imo.

Article of interest here on Expansion Cohorts:( note: all 5 examples in Key Point 3 were for NSCLC)

https://www.clinicalleader.com/doc/fda-issues-guidance-on-expansion-cohorts-in-clinical-trials-of-oncology-drugs-0001
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BDTX News